Publications
December 8, 2022
Presentation: Unlocking the potential of PVRIG & TIGIT pathways to deliver the next transformational cancer immunotherapy drugs
Eran Ophir, SVP Research & Drug Discovery, Compugen, TIGIT Axis Therapies Summit, December 8, 2022
December 8, 2022
Presentation Video: Unlocking the potential of PVRIG & TIGIT pathways to deliver the next transformational cancer immunotherapy drugs
Eran Ophir, SVP Research & Drug Discovery, Compugen, TIGIT Axis Therapies Summit, December 8, 2022
December 6, 2022
Poster 159P: COM701 in combination with nivolumab demonstrates preliminary antitumor activity in patients with platinum resistant epithelial ovarian cancer
Yeku O et al, ESMO-IO 2022
December 6, 2022
Poster 130P: COM701 ± nivolumab – preliminary results of antitumor activity from a Phase 1 study in patients with metastatic NSCLC who have received prior PD-1/PD-L1 inhibitor
Sullivan R et al, ESMO-IO 2022
December 6, 2022
Poster 158P: Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum resistant OVCA
Moroney J.W. et al, ESMO-IO 2022
December 1, 2022
Abstract 420: Triple blockade of the DNAM-axis with COM701 + BMS-986207 + nivolumab demonstrates preliminary antitumor activity in patients with platinum resistant OVCA
Moroney J et al, ESMO-IO 2022
December 1, 2022
Abstract 338: COM701 in combination with nivolumab demonstrates preliminary antitumor activity in patients with platinum resistant epithelial ovarian cancer
Yeku O et al, ESMO-IO 2022
December 1, 2022
Abstract 306: COM701 ± nivolumab – preliminary results of antitumor activity from a Phase 1 study in patients with metastatic NSCLC who have received prior PD-1/PD-L1 inhibitor
Sullivan R et al, ESMO-IO 2022
November 11, 2022
Abstract: PVRIG, a novel T cell checkpoint, is preferentially expressed in TLS on stem-like memory T cells, potentially inhibiting their expansion
Ophir, E, et al, SITC 2022
November 11, 2022
Poster: PVRIG, a novel T cell checkpoint, is preferentially expressed in TLS on stem-like memory T cells, potentially inhibiting their expansion
Ophir, E, et al, SITC 2022